Vertex Pharmaceuticals VRTX SEC Filings

NASDAQ VRTX
$557.96 +1.21 (+0.22%)
At close: Sep 3, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Vertex Pharmaceuticals Inc / Ma (VRTX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index